Navigation Links
Cato Research Ltd. and Advanced Targeting Systems, Inc. Partner to Develop SP-SAP for Chronic Pain
Date:4/3/2008

DURHAM, N.C., and SAN DIEGO, April 3, 2008 /PRNewswire/ -- Cato Research Ltd., a global contract research and development organization, and Advanced Targeting Systems, Inc. (ATS), a privately held biotechnology company, announced today a new strategic alliance focused on development and commercialization of SP-SAP, ATS's lead drug candidate for chronic pain. Advanced Pain Therapeutics LLC (APT), a new strategic development company formed by Cato Research, ATS, and Cato BioVentures, the venture capital affiliate of Cato Research, obtained exclusive, worldwide rights to develop, manufacture, use, and sell SP-SAP for the treatment of severe chronic pain. Cato Research will provide CRO services to the new company.

SP-SAP is a single-dose, nonopioid, substance P receptor-targeted treatment designed to specifically bind to and eliminate a subset of neurons that send the chronic pain signal to the brain. Preclinical studies in animal models have shown that SP-SAP eliminates chronic pain without disrupting other sensory modalities or motor function and is well tolerated.

"When we partner early, as we have here, we can make a major difference in the overall development of promising drug candidates such as SP-SAP," said Lynda Sutton, COO of Cato Research and CEO of Advanced Pain Therapeutics. "The flexible, broad-based relationships among APT, ATS, and Cato Research position us well to execute our innovative drug development model."

Denise Higgins, Vice President of ATS, affirms that this arrangement allows for a unique synergy between the companies. "We are enthusiastic about working with APT and Cato Research to help address the under-served chronic pain population. Our preclinical work with SP-SAP makes us very optimistic about the impact this innovative treatment can have for those who are suffering."

Chronic disease states and tissue damage can lead to chronic pain. In particular, terminally ill patients often experience severe, chronic
'/>"/>

SOURCE Cato Research Ltd.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Diabetes Research, Advocacy and Education Gets Big Boost with Donation of Two- Year Lease for 2008 Chrysler Sebring Convertible
2. Researchers ID gene linked to lung cancer
3. Drexel School of Public Health awarded $14M NIH grant for autism research
4. Conning Research: Long Term Care Insurance Industry Continues to Search for Broader Market
5. Alberta physiologist earns top national honor for spinal cord research
6. Families of children with cancer support human tissue research, study finds
7. USC researchers find new clues to risk of Hodgkin lymphoma
8. Researchers develop new method to test for lung cancer
9. Latest Advances in Diabetes Research to be Presented in San Francisco, California at Worlds Largest Diabetes Conference, June 6-10, 2008
10. UCLA researchers design nanomachine that kills cancer cells
11. New research shows benefits of ultrasound contrast agents outweigh potential risk to heart patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...wswire/ -- Sutter Health, a family of doctors, not...e providers, is donating $255,000 to food banks ac...banks will share the quarter-million-dollar donati...thousands of families across the north state. ,... with and supporting charitable programs and servi...
(Date:11/9/2009)...gs that inhibit estrogen, , , MONDAY, N...breast cancer and osteoporosis eliminated cervical...e drugs also cleared precancerous growths in the c...r in mice with precancerous lesions. , The brea...steoporosis drug raloxifene were given to mice gen...
(Date:11/9/2009)...conditions are age-related, researchers say , ...t surgery doesn,t appear to speed the progression ...ng to a new study that challenges the belief that ...r. , "Because both conditions are strongly age-...AMD," wrote Li Ming Dong, of Stony Brook Universit...
(Date:11/9/2009)...ire-FirstCall/ - Hard To Treat Diseases (HTDS.PK) ...is, a US$41 billion international healthcare compa...e partner, Zhejiang Tianyuan Bio-Pharmaceutical Co...nd will begin a five-year, $1 billion China initia...increase its investment in its China R&D facil...
(Date:11/9/2009)...r Network (NCCN) has posted a draft white paper fo... near-term comparative effectiveness clinical eval...roduces the NCCN Comparative Therapeutic Index(TM)...e risk-versus-benefit of different treatment optio...lines in Oncology(TM). The paper will be posted fo...
Breaking Medicine News(10 mins):Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4
...n Medical School, an injectable gel may be useful ... neck squamous cell carcinoma affects about 20,000...rug cisplatin has been shown to be an effective th...died 120 patients who were previously treated for ...
...found that eating more calories and fats may incre...some people. Previous research has shown that mice.... //Researchers feel this is because of fewer dest...se the damage done by particles found in brains of...
...bout life may not only help you live longer, it ma...he University of Illinois, found two years ago tha...same group of researchers// looked to see if one's...ermined who was optimistic, pessimistic or a mixtu...
...eneficial to our body. When sweet corn is heated, ..., and thereby making it a very healthy addition to...onception that boiling or steaming vegetables and ...nt power than you lose on cooking. For vitam...
...ely poor diet, which adds to the health risks of p...hand smoke accounts for up to 24 per cent of lung ...e smoking - usually because they live with a smoke...in their new survey, that many people living with ...
...because they really don't have allergies," said Sh...of pharmacy at Ohio State University. "They're oft...roblem."// A recent study of 246 patients showed ...rgies; the blood samples from only 35 percent of t...
Other Medicine News:Health News:Diet combined to Alzheimer's disease 2
(Date:11/9/2009)..., NATICK, Mass., Nov. 9 /PRNewswire-FirstCall/ ...ay announced its schedule of events at the 38th an...logy (AAGL), which runs from November 15-19 in Orl...will be presented featuring the Company,s Urology/...truction systems and mid-urethral sling systems us...
(Date:11/9/2009)..., NEW YORK, Nov. 9 /PRNewswire-Asia-FirstCa...E: AOB ), ("the Company" or "AOBO"), a pharmaceut... the development, manufacture and,commercializatio...unter ("OTC"),products, today announced that it pl...s on Monday, November 16, 2009, after the market c...
(Date:11/9/2009)..., SAN DIEGO, Nov. 9, 2009 /PRNewswire-FirstCall...today reported financial results for the third qua...d a lower net loss allocable to common stockholder...r $0.38 per share, compared to a net loss allocabl...008 of $56.2 million, or $0.76 per share, and a ne...
Breaking Medicine Technology:Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Exercise 30 Minutes a Day 3F Who Knew 21 58468 1Exercise 30 Minutes a Day 3F Who Knew 21 58468 2Boston University School of Medicines black womens health study receives 249 1 million award 58465 1Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 1Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 2Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 3Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 4
EBI OsteoGen™-M (Mesh Cathode)
Interference Screws
...crew is indicated for graft fixation in Orthopaedi...s with bone-patellar tendon-bone or soft tissue au...es easy and atraumatic insertions with excellent g...-Reinforced 96L/4D copolymer combines optimal stre...
PHANTOM SofThread Cannulated Interference Screws
Medicine Products: